Tekmira Pharmaceuticals Corp (TKMR) (TKMR)

[Echo20]

TKMR- Jim Cramer,1-10-2013
Tekmira Pharmaceuticals (TKMR)

This company is engaged in a biopharmaceutical business focused on advancing novel RNA interference therapeutics and providing its lipid nanoparticle delivery technology to pharmaceutical partners. This stock is trading up 8.8% to $5.40 in recent trading.

Today’s Range: $5.00-$5.44

52-Week Range: $1.77-$6.78

Volume: 74,000

Three-Month Average Volume: 61,738

From a technical perspective, TKMR is bouncing strongly here right off its 50-day moving average of $4.95 with above-average volume. This stock is quickly moving within range of triggering a near-term breakout trade. That trade will hit once TKMR takes out some near-term overhead resistance levels at $5.35 to $5.78 with high volume. At last check, TKMR have hit an intraday high of $5.45 and volume is just starting to surpass its three-month average action of 61,738 shares.

Traders should now look for long-biased trades in TKMR as long as it’s trending above its 50-day at $4.95, and then once it sustains a move or close above those breakout levels with volume that hits near or above 61,738 shares. If that breakout hits soon, then TKMR will set up to re-test or possibly take out its next major overhead resistance levels at $6 to $6.78.
_____________________________________________________________

TKMR is over 95,000 today on 1-10-2013.

A good PR could lead upwards.

Echo20